Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun 19:36:106.
doi: 10.11604/pamj.2020.36.106.20577. eCollection 2020.

Congenital cytomegalovirus infection as an important cause of infantile cholestatic jaundice: a case report

Affiliations
Case Reports

Congenital cytomegalovirus infection as an important cause of infantile cholestatic jaundice: a case report

Olufunmilola Olubisi Abolurin et al. Pan Afr Med J. .

Abstract

Infantile cholestasis has numerous causes and diagnosis can be difficult, especially in low-income countries where essential laboratory facilities are not readily available. This is a report of a baby who had severe conjugated neonatal hyperbilirubinaemia and deranged liver function tests, which posed a diagnostic dilemma before a diagnosis of congenital cytomegalovirus (CMV) infection was made. He was treated with Ganciclovir and responded well to treatment. He had no obvious associated neurologic manifestation of the disease and is presently been followed-up. This report highlights the challenges encountered in the diagnosis and management of the baby, as well as the favourable outcome with Ganciclovir therapy. The aim of the report is to increase the awareness of paediatricians and other stakeholders on congenital CMV infection in order to ensure early diagnosis and appropriate treatment of affected babies, with the ultimate aim of improving their prognoses and preventing the associated audiologic and cognitive sequelae.

Keywords: Congenital cytomegalovirus; cholestatic jaundice; ganciclovir; hepatitis; infant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Ross SA, Novak Z, Pati S, Boppana SB. Diagnosis of Cytomegalovirus Infections. Infect Disord Drug Targets. 2011;11(5):466–474. - PMC - PubMed
    1. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States. Clin Infect Dis. 2006;43(9):1143–1151. - PubMed
    1. Bates M, Brantsaeter AB. Human cytomegalovirus in Africa: a neglected but important pathogen. J Virus Erad. 2016;2(3):136–142. - PMC - PubMed
    1. Akinbami AA, Rabiu KA, Adewunmi AA, Wright KO, Dosunmu AO, Adeyemo TA, et al. Seroprevalence of cytomegalovirus antibodies amongst normal pregnant women in Nigeria. Int J Women's Health. 2011;3:423–428. - PMC - PubMed
    1. Ogbaini-Emovon E, Lofor PV, Oduyebo O, Ojide KC, Kalu IE, Joseph GA. Incidence and risk of primary cytomegalovirus infection among pregnant women in Benin City Nigeria. Ann Biomed Sci. 2015;14(1)

Publication types

MeSH terms